Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-12

Clinical Trial Update: Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG) [NA]

View source ↗

Summary

This clinical trial update reports that a confirmatory efficacy trial evaluating a gluten-free diet in people with schizophrenia who have high IgG anti-gliadin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia, Gluten Sensitivity | NA | Status: COMPLETED